Hathaway, Quincy A.
Jamthikar, Ankush D.
Rajiv, Nivedita
Chaitman, Bernard R.
Carson, Jeffrey L.
Yanamala, Naveena
Sengupta, Partho P.
Funding for this research was provided by:
National Science Foundation (2125872)
Article History
Received: 16 May 2024
Accepted: 23 July 2024
First Online: 16 September 2024
Declarations
:
: For the internal validation dataset, we identified 155 AMI patients retrospectively from electronic medical record of Robert Wood Johnson University Hospital who were admitted over a 6-month period between January 2023 to July 2023. The Institutional Review Board (IRB) of Robert Wood Johnson University Hospital gave ethical approval for this work (#Pro2023001660). For the external cohort, institutional review boards at each site approved the trial, and patients provided written, informed consent. The study was approved by the Food and Drug Administration (NCT03000270).
: Not applicable.
: Dr. Sengupta is a consultant for RCE Technologies, Echo IQ. Dr. Yanamala is an advisor to Turnkey Learning, LLC and Turnkey Learning (P) Ltd, Pittsburgh, PA, USA. All other authors have no reported disclosures relevant to the contents of this paper to disclose.